Moderna Inc. Files 8-K on Shareholder Votes

Ticker: MRNA · Form: 8-K · Filed: May 5, 2025 · CIK: 1682852

Moderna, Inc. 8-K Filing Summary
FieldDetail
CompanyModerna, Inc. (MRNA)
Form Type8-K
Filed DateMay 5, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote, filing-update

Related Tickers: MRNA

TL;DR

Moderna filed an 8-K on shareholder votes, check their Cambridge HQ details.

AI Summary

Moderna, Inc. filed an 8-K on May 5, 2025, reporting on matters submitted to a vote of security holders as of April 30, 2025. The filing details the company's principal executive offices located at 325 Binney Street, Cambridge, MA 02142, and its telephone number is (617) 714-6500. Moderna, Inc. was formerly known as Moderna Therapeutics, Inc., with a name change effective August 22, 2016.

Why It Matters

This filing provides official updates on corporate governance matters and shareholder votes, which can impact investor confidence and company direction.

Risk Assessment

Risk Level: low — This is a routine filing related to corporate governance and does not appear to contain significant new financial or operational risks.

Key Players & Entities

  • Moderna, Inc. (company) — Registrant
  • Moderna Therapeutics, Inc. (company) — Former company name
  • 325 Binney Street, Cambridge, MA 02142 (location) — Principal executive offices
  • April 30, 2025 (date) — Date of earliest event reported
  • May 5, 2025 (date) — Filing date

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on matters submitted to a vote of security holders as of April 30, 2025.

What is Moderna, Inc.'s principal executive office address?

Moderna, Inc.'s principal executive office is located at 325 Binney Street, Cambridge, MA 02142.

When was Moderna, Inc. formerly known as Moderna Therapeutics, Inc.?

Moderna, Inc. was formerly known as Moderna Therapeutics, Inc., with a date of name change effective August 22, 2016.

What is the telephone number for Moderna, Inc.'s principal executive offices?

The telephone number for Moderna, Inc.'s principal executive offices is (617) 714-6500.

What is the SEC file number for Moderna, Inc.?

The SEC file number for Moderna, Inc. is 001-38753.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 5, 2025 regarding Moderna, Inc. (MRNA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.